Cancer Medicine Prices Fell Yesterday. 137 Drugs.
The Take
From November 9, the maximum retail prices of 137 anti-cancer medicines dropped. The NPPA capped trade margins across 1,225 formulations from 76 manufacturers. Over 600 brands fell by more than half, and the steepest cut reaches 96 percent. Hospitals and shops must display the new lists. The regulator counted Rs 3,502 crore in yearly savings. Cheaper finally shipped.
The Wire
Revised maximum retail prices for 137 anti-cancer medicines take effect on November 9, with the NPPA's margin cap covering 1,225 formulations from 76 manufacturers, PIB and Livemint report. NDTV notes estimated annual consumer savings of Rs 3,502 crore. More than 600 brands fall by over 50 percent, and retailers and hospitals must display the revised price lists publicly.
The receipts
Source: www.pib.gov.in